A. Pletscher

12.1k total citations · 1 hit paper
309 papers, 9.5k citations indexed

About

A. Pletscher is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, A. Pletscher has authored 309 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Molecular Biology, 89 papers in Cellular and Molecular Neuroscience and 41 papers in Pharmacology. Recurrent topics in A. Pletscher's work include Neurotransmitter Receptor Influence on Behavior (56 papers), Neuroscience and Neuropharmacology Research (42 papers) and Receptor Mechanisms and Signaling (37 papers). A. Pletscher is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (56 papers), Neuroscience and Neuropharmacology Research (42 papers) and Receptor Mechanisms and Signaling (37 papers). A. Pletscher collaborates with scholars based in Switzerland, United States and Chile. A. Pletscher's co-authors include G. Bartholini, M. Da Prada, K.F. Gey, Bernard B. Brodie, W.P. Burkard, Parkhurst A. Shore, Sidney Udenfriend, Donald F. Bogdanski, J. P. Tranzer and H. H. Keller and has published in prestigious journals such as Nature, Science and The Journal of Cell Biology.

In The Last Decade

A. Pletscher

302 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDENTIFICATION AND ASSAY OF SEROTONIN IN BRAIN

1956 764 citations A. Pletscher et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

Countries citing papers authored by A. Pletscher

Since Specialization

Citations

This map shows the geographic impact of A. Pletscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Pletscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Pletscher more than expected).

Fields of papers citing papers by A. Pletscher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Pletscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Pletscher. The network helps show where A. Pletscher may publish in the future.

Co-authorship network of co-authors of A. Pletscher

This figure shows the co-authorship network connecting the top 25 collaborators of A. Pletscher. A scholar is included among the top collaborators of A. Pletscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Pletscher. A. Pletscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The controversial early history of cyclosporin 2001 ·Swiss Medical Weekly ·(unknown), A. Pletscher	38
2	The discovery of antidepressants: A winding path 1991 ·Cellular and Molecular Life Sciences ·A. Pletscher	63
3	Modulation of gene expression by high and low density lipoproteins in human vascular smooth muscle cells 1991 ·Biochemical and Biophysical Research Communications ·Alfred W.A. Hahn, Fabrizia Ferracin, Fritz R. Bühler, A. Pletscher	17
4	Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: Clinical relevance 1990 ·Cardiovascular Drugs and Therapy ·(unknown), A. Pletscher, Fabrizia Ferracin, (unknown), Fritz R. Bühler	17
5	Rapid activation of human platelets by low concentrations of low‐density lipoprotein via phosphatidylinositol cycle 1988 ·European Journal of Biochemistry ·(unknown), Rudolf Locher, Esther Vogt, W. Vetter, (unknown), Fabrizia Ferracin, (unknown), A. Pletscher	78
6	Serotonin Metabolism and Age-Related Effects of Antihypertensive Therapy with Ketanserin 1988 ·Drugs ·(unknown), (unknown), (unknown), A. Pletscher, Fritz R. Bühler	6
7	Low-density lipoprotein enhances platelet activation in parallel with the height of blood pressure 1988 ·Journal of Hypertension ·(unknown), (unknown), Fabrizia Ferracin, Fritz R. Bühler, A. Pletscher	6
8	Platelets as models: Use and limitations 1988 ·Cellular and Molecular Life Sciences ·A. Pletscher	81
9	LIBERATION OF CATECHOLAMINES FROM BLOOD PLATELETS 1981 ·British Journal of Pharmacology ·A. Pletscher	15
10	Subcellular localization of the heparin‐neutralizing factor in blood platelets. 1976 ·The Journal of Physiology ·M. Da Prada, Milica Jakábová, E. F. Lüscher, A. Pletscher, John Richards	28
11	SUBCELLULAR DISTRIBUTION OF RESERPINE IN BLOOD PLATELETS: EVIDENCE FOR MULTIPLE POOLS 1974 ·Journal of Pharmacology and Experimental Therapeutics ·S.J. Enna, M. Da Prada, A. Pletscher	11
12	THE EFFECT OF 5,6-DIHYDROXYTRYPTAMINE ON UPTAKE, STORAGE AND METABOLISM OF 5-HYDROXYTRYPTAMINE BY BLOOD PLATELETS 1973 ·Journal of Pharmacology and Experimental Therapeutics ·M. Da Prada, R.A. O'Brien, J. P. Tranzer, A. Pletscher	9
13	Action of reserpine and imipramine on intracellular storage of 5-hydroxytryptamine in blood platelets 1967 ·Cellular and Molecular Life Sciences ·A. Pletscher, J. P. Tranzer	16
14	Ultrastructural Localization of 5-Hydroxy-tryptamine in Blood Platelets 1966 ·Nature ·J. P. Tranzer, M. Da Prada, A. Pletscher	124
15	Inhibition of cerebral decarboxylase and behaviour 1964 ·International Journal of Neuropharmacology ·A. Pletscher, M. Da Prada, Felix Steiner	10
16	EFFECTS OF CHLORPROMAZINE ON THE METABOLISM OF dl-2-C14-DOPA IN THE RAT 1964 ·Journal of Pharmacology and Experimental Therapeutics ·K.F. Gey, A. Pletscher	10
17	INFLUENCE OF CHLORPROMAZINE AND CHLORPROTHIXENE ON THE CEREBRAL METABOLISM OF 5-HYDROXYTRYPTAMINE, NOREPINEPHRINE AND DOPAMINE 1961 ·Journal of Pharmacology and Experimental Therapeutics ·K.F. Gey, A. Pletscher	74
18	Increase of free 5-hydroxytryptamine in blood plasma by reserpine and a benzoquinolizine derivative 1959 ·Cellular and Molecular Life Sciences ·M. K. Paasonen, A. Pletscher	21
19	SIGNIFICANCE OF MONOAMINE OXIDASE INHIBITION FOR THE PHARMACOLOGICAL AND CLINICAL EFFECTS OF HYDRAZINE DERIVATIVES 1959 ·Annals of the New York Academy of Sciences ·A. Pletscher	19
20	[Diagnostic significance of urinary excretion of 5-hydroxyindoleacetic acid]. 1957 ·PubMed ·Eric V. Granowitz, A. Pletscher	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact